| Literature DB >> 35444992 |
Fatme Al Anouti1, Justin Thomas2, Spyridon Karras3, Nour El Asswad4.
Abstract
Background: The COVID-19 pandemic and the associated infection prevention and control measures had a negative impact on the mental health of many people. In the United Arab Emirates (UAE), infection control measures implemented after March 24th, 2020, placed necessary restrictions on people's freedom of movement. Aim: This study aimed to assess the association between levels of daytime vs. nighttime outdoor activity and mental health among a sample of UAE residents during the lockdown period. Method: An opportunity sample of 245 participants completed an online survey assessing levels of depression, somatic symptoms, daytime and nighttime activity levels.Entities:
Keywords: COVID-19; United Arab Emirates; depressive symptoms; somatization; vitamin D
Mesh:
Year: 2022 PMID: 35444992 PMCID: PMC9013851 DOI: 10.3389/fpubh.2022.829362
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Means and standard deviations for endorsement of outdoor activities.
|
|
|
| ||
|---|---|---|---|---|
|
|
|
|
| |
| Being on an outdoor balcony | 0.93 | 1.15 | 0.84 | 1.12 |
| Being in a garden or yard | 0.99 | 1.17 | 0.78 | 1.09 |
| Walking outdoors | 1.00 | 1.15 | 0.89 | 1.09 |
| Being on a roof or outdoor terrace | 0.49 | 0.92 | 0.54 | 0.99 |
| Outdoor exercise | 0.56 | 0.98 | 0.49 | 0.94 |
SD, Standard Deviation.
Means and standard deviations for psychopathology symptom measures.
|
|
|
| |
|---|---|---|---|
| Depression | 9.93 | 7.30 | 47.95 |
| Somatization | 7.56 | 5.77 | 34.31 |
SD, Standard Deviation.
Correlations for all the main variables of the study.
|
|
|
| ||
|---|---|---|---|---|
| Somatization | 0.659 | −0.043 | −0.195 | −0.088 |
| Depression | −0.078 | −0.189 | −0.109 | |
| VTD suppl. | 0.016 | 0.100 | ||
| Day activity | 0.646 |
p < 0.05,
p < 0.01,
p < 0.001.
Bivariate and multivariate logistic regression predicting depressive symptoms.
|
|
| |||
|---|---|---|---|---|
|
| ||||
|
| ||||
| No | 125 | 39 (31.2%) | - | - |
| Yes | 120 | 81 (67.5%) | 4.587 | 4.032 |
|
| ||||
| Male | 46 | 12 (26.0%) | - | - |
| Female | 199 | 108 (54.2%) | 3.363 | 2.531 |
|
| ||||
| No | 91 | 32 (35.1%) | - | - |
| Yes | 154 | 88 (57.1%) | 2.458 | 0.937 |
|
| ||||
| Yes | 70 | 23 (22.8%) | - | - |
| No | 175 | 97 (55.4%) | 2.541 | 2.458 |
|
| ||||
| Yes | 64 | 27 (42.1%) | - | - |
| No | 181 | 93 (51.3%) | 1.448 | |
|
| ||||
| No | 141 | 74 (44.2%) | - | - |
| Yes | 104 | 46 (52.4%) | 1.393 | |
p < 0.05,
p < 0.01,
p < 0.001.
Figure 1Multivariate logistic regression model analysis for higher risk of clinically significant depressive symptoms with adjusted odds ratios for all variables.
Bivariate and multivariate logistic regression predicting somatic symptoms.
|
|
| |||
|---|---|---|---|---|
|
| ||||
|
| ||||
| No | 119 | 22 (18.4%) | - | - |
| Yes | 120 | 59 (49.1%) | 4.273 (2.375–7.633) | 3.690 (1.782–7.633) |
|
| ||||
| Male | 46 | 4 (8.6%) | - | - |
| Female | 193 | 77 (39.8%) | 6.970 (2.403– 20.218) | 5.505 (1.1827–16.58) |
|
| ||||
| No | 87 | 19 (21.8%) | - | - |
| Yes | 152 | 62 (42.7% | 2.465 (1.349–4.505) | 0..941 (0.429–2.061) |
|
| ||||
| Yes | 67 | 15 (22.3%) | - | - |
| No | 172 | 66 38.3%) | 2.158 (1.125–4.141) | 2.119 (1.053–4.265) |
|
| ||||
| Yes | 62 | 19 (30.6%) | - | - |
| No | 177 | 62 (35.0%) | 1.220 (0.655–2.273) | |
|
| ||||
| Yes | 101 | 32 (31.6%) | - | - |
| No | 138 | 49 (35.5%) | 1.187 (0.688–2.048) | |
p < 0.05,
p < 0.01,
p < 0.001.
Figure 2Multivariate logistic regression model analysis for higher risk of clinically significant somatic symptoms with adjusted odds ratios for all variables.